Shenzhen Sangel Venture Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
3
- Investments
-
82
- Portfolio
-
45
- Exits
-
21
Shenzhen Sangel Venture Capital General Information
Company Description
Founded in 2009, Shenzhen Sangel Venture Capital is a venture capital firm based in Shenzhen, China. The firm seeks to invest in biomedical companies with a focus on life science, biotech, biopharma, medical devices, and digital health sectors.
Business Details
Website
www.sangelvc.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 2401/2402, Shenzhen Bay Venture Capital Building
- Nanshan District
- Shenzhen, Guangdong
- China
Shenzhen Sangel Venture Capital Investments (82)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Hengkangyuan | 02-Feb-2026 | Seed Round | Biotechnology | Startup | ||
| First Imaging | 28-May-2025 | Diagnostic Equipment | Generating Revenue | |||
| Henglu Biotechnology | 01-Nov-2024 | Biotechnology | Generating Revenue | |||
| First Imaging | 12-May-2024 | Diagnostic Equipment | Generating Revenue | |||
| OxTium | 25-Jan-2024 | Decision/Risk Analysis | Generating Revenue | |||
| China TopDent Online | 13-Nov-2023 | Enterprise Systems (Healthcare) | Generating Revenue | |||
| Glycogene | 27-Mar-2023 | Biotechnology | Generating Revenue | |||
| Proviva Therapeutics | 05-Mar-2023 | Discovery Tools (Healthcare) | Generating Revenue | |||
| BioTroy Therapeutics | 31-Jan-2023 | Early Stage VC | Biotechnology | Generating Revenue | ||
| Aixindawei Pharmaceutical | 15-Nov-2022 | Later Stage VC | Drug Discovery | Generating Revenue |
Shenzhen Sangel Venture Capital Exits (21)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Longbio Pharma | 05-Jun-2026 | IPO | |
| Virogin Biotech | 01-Jun-2026 | ||
| OrphAI Therapeutics | 18-May-2026 | ||
| Henglu Biotechnology | 19-Nov-2025 | ||
| Ultivue | 09-Oct-2024 | ||
| Refuge Biotech | 03-Aug-2023 | ||
| Thistory | 29-Mar-2023 | ||
| InnerMed | 31-Dec-2022 | ||
| 3D Medicines | 15-Dec-2022 | IPO | |
| Aucta Pharmaceuticals | 28-Sep-2022 | Secondary Transaction - Private |
Shenzhen Sangel Venture Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Shenzhen Sangel Venture Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Shenzhen Sangel Venture Capital Co-Investors (16)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Shanghai Shifeng Xinhui Venture Capital Management | 2 |
|
|
||
| Co-Win Ventures |
|
|
|||
| Horus Capital (China) |
|
|
|||
| Lapam Capital |
|
|
|||
| Tech Intelligence Capital |
|
|
Shenzhen Sangel Venture Capital FAQs
-
What is Shenzhen Sangel Venture Capital?
Founded in 2009, Shenzhen Sangel Venture Capital is a venture capital firm based in Shenzhen, China.
-
When was Shenzhen Sangel Venture Capital founded?
Shenzhen Sangel Venture Capital was founded in 2009.
-
Where is Shenzhen Sangel Venture Capital headquartered?
Shenzhen Sangel Venture Capital is headquartered in Shenzhen, China.
-
What is Shenzhen Sangel Venture Capital's total asset value?
Shenzhen Sangel Venture Capital has around in total assets under management.
-
How many investments has Shenzhen Sangel Venture Capital made?
Shenzhen Sangel Venture Capital has made 82 investments.
-
What has Shenzhen Sangel Venture Capital invested in?
Shenzhen Sangel Venture Capital has made numerous investments in companies like Hengkangyuan, First Imaging, and Henglu Biotechnology within the Biotechnology and Diagnostic Equipment industries.
-
What has Shenzhen Sangel Venture Capital invested in recently?
Shenzhen Sangel Venture Capital's latest investment was on 02-Feb-2026 in Hengkangyuan, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
